Iran has launched production of the Russian Sputnik V coronavirus vaccine. As the head of the Russian Direct Investment Fund Kirill Dmitriev said earlier, this country will be one of the key producers of the drug.
“Iran’s leading pharmaceutical manufacturer is starting production of Sputnik V with a first trial batch,” the source said. Twitter vaccines. The message specifies that the drug will be used in the vaccination program for the country’s population.
Iran produced trial batches of Sputnik V in early June. As previously reported, two Iranian pharmaceutical companies were involved in this work. The country approved the Russian vaccine on January 26, then Moscow and Tehran agreed on its supply and production.
According to Johns Hopkins University, more than 3 million cases have been registered in Iran since the beginning of the pandemic, 83.5 thousand people with confirmed COVID-19 have died.